Results 171 to 180 of about 5,699 (211)

The role of regulatory T cells in familial Mediterranean fever (FMF)

Clinical Rheumatology, 2012
The role of regulatory T cells (T-regs) in familial Mediterranean fever (FMF) was never evaluated. Preliminary studies that we have conducted suggested a rise in the number of regulatory T cells after FMF attacks reaching a maximal level at 7 days. The aim of this study was to evaluate the percentage and activity of regulatory T cells in FMF.
D, Rimar, I, Rosner, G, Slobodin, N, Boulman, E, Toubi, A, Kessel, R, Peri, M, Rozenbaum   +7 more
openaire   +2 more sources

Blood Oxidative Stress Biomarkers in Patients with Familial Mediterranean Fever (FMF)

Aktuelle Rheumatologie, 2009
Interest in the relationship between oxidative stress and inflammation has increased in recent years. Familial Mediterranean fever (FMF) represents a suitable autoinflammatory disease model for investigation of this relationship. We aimed to determine blood oxidative stress biomarkers in patients with FMF in both acute attacks and in attack-free ...
Çelik, Serkan, Öktenli, Çağatay, Terekeci, Murat Hakan, İpçioğlu, Osman, Sanisoğlu, Yavuz S., Sayan, Özkan, Yeşilova, Zeki, Yıldız, Oğuzhan, Tunca, Yusuf, Nalbant, Selim   +9 more
openaire   +3 more sources

Familial Mediterranean Fever (FMF)

2014
Familial Mediterranean Fever (FMF) is an autosomal recessive genetic disease that affects males and females. FMF gene is on the short arm of chromosome 16. It is most often found in Jews, Arabs, Turks, and Armenians. Amyloidosis is charecterized by the deposition of a particular protein between the cells in the tissue.
ALBAYRAK, Onur, ÇÜRÜK, M. Akif
openaire   +1 more source

Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF)

Clinical Rheumatology, 2012
The association between familial Mediterranean fever (FMF) and subclinical cardiac disease remains controversial. The aim of the current study was to evaluate whether FMF patients, who do not respond to colchicine treatment, and thereby endure persistent inflammation, have increased QT dispersion (QTd) values.
Udi, Nussinovitch, Avi, Livneh, Benjamin, Volovitz, Moshe, Nussinovitch, Ilan, Ben-Zvi, Merav, Lidar, Naomi, Nussinovitch   +6 more
openaire   +2 more sources

A novel cluster of patients with Familial Mediterranean Fever (FMF) in southern Italy

European Journal of Clinical Investigation, 2017
AbstractBackgroundFamilial Mediterranean Fever (FMF) is an autosomal recessive autoinflammatory disorder characterised by recurrent attacks of fever and serositis (peritonitis, pleuritic or synovitis) affecting mainly populations of Mediterranean origin.AimTo describe a relatively new cluster of FMF subjects from Apulia and Basilicata regions (southern
Leonilde Bonfrate, Giuseppe Scaccianoce, Giuseppe Palasciano, Eldad Ben‐Chetrit, Piero Portincasa   +4 more
openaire   +3 more sources

[Familial Mediterranean fever (FMF) (author's transl)].

Anales espanoles de pediatria, 1981
Authors present an Andalusian family, affected by FMF with a dominant autosomal inheritance. The number of members affected by phenotype II (40%) and the cases of bad prognosis (1/3 died before 34 years of age) was higher than those found by other authors.
M A, Ribó Golovart, M, Gassó Campos, B, Esteban Velasco, M A, Castellá Ribó, R, Pulido Bosch   +4 more
openaire   +1 more source

The immune regulation in familial Mediterranean fever (FMF).

Journal of clinical & laboratory immunology, 1989
In order to investigate a possible immune regulation imbalance in familial Mediterranean fever (FMF), the T-cell subsets and interleukin (IL)-1 and -2 production were examined in 39 patients (32 consecutive; 7 previous) and 14 controls. Results in the FMF group indicated no change in total T-cells and B-cells.
A, Melamed, S, Cabili, V, Zakuth, Z, Spirer   +3 more
openaire   +1 more source

The Impact of Colchicine on the Amyloidosis of Familial Mediterranean Fever (FMF)

1986
Since Goldfinger’s observation in 1972 that daily administration of colchicine may prevent the attacks of familial Mediterranean fever [1], the drug has become the mainstay of therapy and is recommended to all of our many afflicted. On a dose of 102 mg/day, 95% of patients experience complete remission or marked amelioration of their attacks.
D. Zemer, E. Sohar, M. Pras, S. Cabili, J. Gafni   +4 more
openaire   +1 more source

Familial Mediterranean Fever (FMF) and Pregnancy: Literature Review

Nauchno-prakticheskii zhurnal «Medicinskaia genetika», 2020
В обзоре обобщается текущая информация о влиянии семейной средиземноморской лихорадки (ССЛ) и ее лечения на исходы беременности, анализируется вопрос гипотетической тератогенности колхицина. В случае резистентности/непереносимости колхицина обсуждается возможность использования других лекарственных средств во время беременности, в том числе, генно ...
openaire   +1 more source

The arthritis of familial mediterranean fever (FMF)

Arthritis & Rheumatism, 1966
H, Heller, J, Gafni, D, Michaeli, N, Shahin, E, Sohar, G, Ehrlich, I, Karten, L, Sokoloff   +7 more
openaire   +2 more sources